A Study Investigating the Efficacy and Safety of ABT-494 Given With Methotrexate in Subjects With Rheumatoid Arthritis Who Failed Anti-Tumor Necrosis Factor (TNF) Biologic Therapy

PHASE2CompletedINTERVENTIONAL

Enrollment

276

Participants

Timeline

Start Date

October 31, 2013

Primary Completion Date

July 31, 2015

Study Completion Date

July 31, 2015

Conditions

Rheumatoid Arthritis

Interventions

DRUG

ABT-494

ABT-494 capsule administered orally twice daily (BID).

DRUG

Placebo

Placebo for ABT-494 capsule administered orally twice daily (BID).